Intrathecal immunoglobulin M production: A promising high-risk marker in clinically isolated syndrome patients.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 29665046.
- Also identified by DOI 10.1002/ana.25237.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Markers predicting the course of patients with clinically isolated syndrome (CIS) toward multiple sclerosis (MS) are urgently needed. We evaluated the predictive values of intrathecal immunoglobulin (Ig) G and IgM production with different methods for conversion to definite MS according to revised McDonald 2010 criteria in a cohort of 126 CIS patients. Intrathecal IgM production showed the highest likelihood ratio for the conversion of CIS patients to definite MS at 6.3, whereas it was 1.4 for oligoclonal IgG bands. We conclude that the determination of intrathecal IgM is a valuable tool to predict the disease course of patients with CIS. Ann Neurol 2018;83:1032-1036.
Medical subject headings
- Biomarkers
- Demyelinating Diseases
- Immunoglobulin G
- Immunoglobulin M